B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Kenpaullone

8 PubMed studies analyzed ยท Evidence Score: 25.2

Research Domains

Kenpaullone has been studied across 8 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿง  Neuroprotection, ๐Ÿง  Memory, ๐Ÿง  Learning, ๐Ÿ”ฌ Inflammation. The primary research focus is ๐Ÿ”ฌ Oncology with 50% of studies addressing this area.

Loading evidence profile...

This evidence profile for Kenpaullone is generated deterministically from 8 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.